Connection

Robert Adams to Ultrasonography, Doppler, Transcranial

Back to Details
This is a "connection" page, showing publications Robert Adams has written about Ultrasonography, Doppler, Transcranial.
Robert Adams
Connection Strength
5.320
Ultrasonography, Doppler, Transcranial
  1. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
    View in: PubMed
    Score: 0.741
  2. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
    View in: PubMed
    Score: 0.524
  3. Should TCD be used to force parents to allow transfusion? Pediatr Blood Cancer. 2010 Jan; 54(1):11-2.
    View in: PubMed
    Score: 0.327
  4. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep; 49(3):318-22.
    View in: PubMed
    Score: 0.278
  5. Transcranial Doppler ultrasonography in adults with sickle cell disease. Neurology. 2006 Aug 22; 67(4):572-4.
    View in: PubMed
    Score: 0.259
  6. TCD in sickle cell disease: an important and useful test. Pediatr Radiol. 2005 Mar; 35(3):229-34.
    View in: PubMed
    Score: 0.233
  7. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.217
  8. Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol. 2003 Nov; 54(5):559-63.
    View in: PubMed
    Score: 0.213
  9. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
    View in: PubMed
    Score: 0.182
  10. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000 Nov; 30(11):733-8.
    View in: PubMed
    Score: 0.173
  11. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
    View in: PubMed
    Score: 0.169
  12. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol. 2000 May; 15(5):344-9.
    View in: PubMed
    Score: 0.167
  13. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
    View in: PubMed
    Score: 0.164
  14. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019 12; 94(12):1335-1343.
    View in: PubMed
    Score: 0.161
  15. Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition. Br J Haematol. 2018 04; 181(2):242-251.
    View in: PubMed
    Score: 0.144
  16. TCD in sickle cell disease. J Pediatr Hematol Oncol. 1996 Aug; 18(3):331-4.
    View in: PubMed
    Score: 0.129
  17. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
    View in: PubMed
    Score: 0.123
  18. Transcranial Doppler correlation with angiography in detection of intracranial stenosis. Stroke. 1994 Oct; 25(10):1931-4.
    View in: PubMed
    Score: 0.113
  19. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood. 2014 Aug 07; 124(6):891-8.
    View in: PubMed
    Score: 0.111
  20. Prevention of stroke in sickle cell anemia. J Law Med Ethics. 2014; 42(2):135-8.
    View in: PubMed
    Score: 0.108
  21. Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine. 2012 Oct; 60(1):302-8.
    View in: PubMed
    Score: 0.097
  22. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer. 2011 May; 56(5):777-82.
    View in: PubMed
    Score: 0.087
  23. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010 Feb; 54(2):256-9.
    View in: PubMed
    Score: 0.082
  24. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009 Apr 14; 72(15):1316-21.
    View in: PubMed
    Score: 0.078
  25. Big strokes in small persons. Arch Neurol. 2007 Nov; 64(11):1567-74.
    View in: PubMed
    Score: 0.070
  26. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec 29; 353(26):2769-78.
    View in: PubMed
    Score: 0.062
  27. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72.
    View in: PubMed
    Score: 0.057
  28. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.037
  29. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.036
  30. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
    View in: PubMed
    Score: 0.030
  31. Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
    View in: PubMed
    Score: 0.026
  32. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.023
  33. Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010 Jan; 49(1):39-44.
    View in: PubMed
    Score: 0.020
  34. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006 Aug; 134(3):333-9.
    View in: PubMed
    Score: 0.016
  35. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006 Aug 01; 108(3):847-52.
    View in: PubMed
    Score: 0.016
  36. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
    View in: PubMed
    Score: 0.013
  37. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet. 2003 Jul 18; 4:6.
    View in: PubMed
    Score: 0.013
  38. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001 Dec; 58(12):2017-21.
    View in: PubMed
    Score: 0.012
  39. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.